Embla Medical hf. (OTCMKTS:OSSFF – Get Free Report) was the target of a significant increase in short interest in July. As of July 31st, there was short interest totaling 95 shares, an increase of ? from the July 15th total of 0 shares. Based on an average daily volume of 2 shares, the days-to-cover ratio is currently 47.5 days.
Embla Medical hf. Price Performance
OSSFF opened at $4.15 on Friday. The stock’s fifty day moving average is $4.15 and its 200-day moving average is $4.35. Embla Medical hf. has a one year low of $4.15 and a one year high of $5.33.
About Embla Medical hf.
Embla Medical hf., headquartered in Reykjavik, Iceland, develops and manufactures diagnostic medical devices for sleep, respiratory and neurophysiological monitoring. The company is publicly listed on Nasdaq Iceland and trades in the United States on the OTC market under the symbol OSSFF.
Embla Medical’s engineering and R&D teams design comprehensive solutions that combine hardware, sensors, electrodes and analysis software. Its portfolio includes ambulatory sleep assessment systems suitable for both in-lab and home-based polysomnography, as well as open-platform devices capable of capturing bioelectrical signals such as EEG, ECG and respiratory effort.
Beyond sleep diagnostics, the company’s technology supports respiratory care monitoring and neurophysiology research.
Further Reading
- Five stocks we like better than Embla Medical hf.
- AMG’s Alternatives Boom Powers Record Growth
- Microsoft’s Maia 300 Chip Targets NVIDIA’s AI Dominance
- 3 Unexpected ETFs Crushing the Market This Summer
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
Receive News & Ratings for Embla Medical hf. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embla Medical hf. and related companies with MarketBeat.com's FREE daily email newsletter.
